ArticleJournal of Cancer2018

Concurrent Chemoradiotherapy with Docetaxel, Cisplatin, and 5-fluorouracil Improves Survival of Patients with Advanced Esophageal Cancer Compared with Conventional Concurrent Chemoradiotherapy with Cisplatin and 5-fluorouracil.

Yukihisa Tamaki et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.